Abstract: The invention relates to a Mangifera (Mango) Indica preparation as Sirtuin 1 activating agent for in vivo and in vitro applications. The preparation may be used to reduce the risk of developing obesity, type II diabetes, elevated blood lipid levels, artheriosclerosis and cardiovascular diseases, as well as a cell and DNA protector.

Abstract: The invention relates to a Mangifera (Mango) Indica preparation as Sirtuin 1 activating agent for in vivo and in vitro applications. The preparation may be used to reduce the risk of developing obesity, type II diabetes, elevated blood lipid levels, artheriosclerosis and cardiovascular diseases, as well as a cell and DNA protector.

Abstract: Provided are food, dietary supplements and/or drug compositions having prebiotic effect and their use in human and animal care.

Abstract: Provided are compositions comprising an active ingredient having antispasmodic and/or prokinetic activity, preferably vicenin 2 or biologically active analogs thereof.

Abstract: Disclosed are food compositions, comprising aqueous extracts of Melissa officinalis (Lemon balm) and/or its active principle rosmarinic acid. Methods of preparing a food composition, and of making a medicament, both methods comprising rosmarinic acid and/or aqueous extracts of Melissa officinalis, are also disclosed.

Abstract: The invention relates to an active ingredient and/or to a composition having beneficial effect on neurological and cognitive functions.

Abstract: Provided are compositions comprising an active ingredient having antispasmodic and/or prokinetic activity, preferably vicenin 2 or biologically active analogues thereof.

Abstract: Disclosed are food compositions, comprising aqueous extracts of Melissa officinalis (Lemon balm) and/or its active principle rosmarinic acid. Methods of preparing a food composition, and of making a medicament, both methods comprising rosmarinic acid and/or aqueous extracts of Melissa officinalis, are also disclosed.

Abstract: Processes for the production of Hoodia plant extracts with a high content of steroidal glycosides and for minimizing heavy metal and/or polyaromatic hydrocarbon content in Hoodia extracts.

Abstract: Compositions containing extracts of Aloe which are suitable for dietary supplements and/or functional food products are disclosed. The compositions which further comprise extracts of other plants are also disclosed. The compositions of extracts of Aloe in combination with chitosans, fatty acids, sterols and/or sterol esters are additionally disclosed. The compositions disclosed induce satiety and/or reduce the appetite.

Abstract: Novel extracts from the leaves of Ginkgo biloba, comprising 20 to 30%, by weight, of flavone glycosides; 2.5 to 4.5%, by weight in the aggregate, of ginkgolides A, B, C and J; 2.0 to 4.0%, by weight, of bilobalides; less than 10 ppm of alkyl phenol compounds; and more than 10%, by weight, of oligomeric proanthocyanidins, useful for pharmaceutical, dietary supplements and/or functional food/nutraceutical compositions, and a novel process for obtaining such extracts.

Abstract: Processes for the production of Hoodia plant extracts with a high content of steroidal glycosides and for minimizing heavy metal and/or polyaromatic hydrocarbon content in Hoodia extracts.

Abstract: Compositions for oral administration of (a) a physiologically active fatty acid containing about 16 to 26 carbon atoms and about 2 to 6 double bonds, and esters or glycerides thereof; and (b) an oligomeric proanthocyanidin or a plant extract containing said proanthocyanidin are disclosed. Methods of using the compositions as additives in food products are also disclosed.

Abstract: Disclosed are cosmetic preparations and, more particularly, skin and hair care and cleaning products with an amount of at least one glycyrrhetic antibacterial agent selected from glycyrrhetic acid, glycyrrhetic acid derivatives and extracts of Glycyrrhiza glabra, and their salts, effective to inhibit or prevent the growth of bacteria. The cosmetic preparations may include other antibacterial or antibiotic agents. The glycyrrhetic antibacterial agent and, optionally, the antibacterial or antibiotic agents may be provided in microencapsulated form. Also disclosed is the use of such cosmetic preparations for treating acne.